Digestive Health

Available Digestive Health Trials:

• (139-24) Endoscopic Ultrasound with Shear Wave Elastography for the Assessment of Liver Disease

• (161-24) A Multicenter Randomized, Double-blind, Sham-controlled Study Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals with Type 2 Diabetes (ReCET Study)

• (162-24) A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF EFRUXIFERMIN IN SUBJECTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)/METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)

• (190-25) A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients with Normal Gastric Emptying using the Enterra® Therapy System (NAVIGATE)

• (195-25) Gastric Electrical Stimulation using Enterra™ Therapy for Clinical Use in Patients with Refractory Nausea and Vomiting and Gastroparesis

• (199-24) A phase 2b, multicenter, double-blind, placebo-controlled, study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of obefazimod in subjects with moderately to severely active Crohn’s disease

• (222-24) A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy with RO7790121 in Patients with Moderately to Severely Active Ulcerative Colitis

• (226-24) BOOM-IBD2 Pivotal Trial

• (260-24) A Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who are Naïve to Targeted Therapies

To learn more about available clinical trials, please at 949-764-4577 or clinicalresearch@hoag.org.